Houillier Pascal, Prot-Bertoye Caroline
Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université Paris Cité, Paris, France; CNRS ERL 8228 - Laboratoire de Physiologie Rénale et Tubulopathies, Paris, France; Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Service de Physiologie, Paris, France; Centre de Référence des Maladies Rénales Héréditaires de l'Enfant et de l'Adulte (MARHEA), Paris, France; Centre de Référence des Maladies Rares du Calcium et du Phosphate, Paris, France; and Faculté de Médecine, Université Paris Cité, Paris, France.
J Am Soc Nephrol. 2025 Apr 1;36(4):706-712. doi: 10.1681/ASN.0000000628. Epub 2025 Jan 9.
The renal tubule and collecting duct express a large number of proteins, all having putative immunoreactive motives. Therefore, all can be the target of pathogenic autoantibodies. However, autoimmune tubulopathies seem to be rare, and we hypothesize that they are underdiagnosed. This review summarizes the current knowledge on autoimmune tubulopathies. We elected to classify tubulopathies according to the segment that is targeted because this determines, at least in part, the phenotypic presentation. In the proximal tubule, autoantibodies can cause anti-brush border antibody disease, renal Fanconi syndrome, renal proximal tubular acidosis, or tubulointerstitial nephritis and uveitis syndrome. Autoantibodies targeting the thick ascending limb of the loop of Henle can cause either acquired Bartter syndrome or hypomagnesemia with hypercalciuria, whereas autoantibodies targeting the distal convoluted tubule can cause acquired Gitelman syndrome. Finally, renal distal tubular acidosis or nephrogenic diabetes insipidus can be caused by autoantibodies targeting the collecting duct. In most instances, the characterization of the autoantibodies remains incomplete and the pathogenesis of the disease obscure. We believe it is important to increase the awareness of physicians regarding autoantibody-mediated tubular diseases to have a better estimation of the prevalence and to improve the care to patients. A research effort to increase the understanding of the pathogenesis of autoantibodies-mediated tubular diseases is also hoped for.
肾小管和集合管表达大量蛋白质,所有这些蛋白质都具有假定的免疫反应基序。因此,它们都可能成为致病性自身抗体的靶点。然而,自身免疫性肾小管病似乎很少见,我们推测它们存在诊断不足的情况。本综述总结了目前关于自身免疫性肾小管病的知识。我们选择根据所靶向的节段对肾小管病进行分类,因为这至少在一定程度上决定了表型表现。在近端小管,自身抗体可导致抗刷状缘抗体病、肾性范可尼综合征、肾近端肾小管酸中毒或肾小管间质性肾炎和葡萄膜炎综合征。靶向髓袢升支粗段的自身抗体可导致获得性巴特综合征或伴高钙尿症的低镁血症,而靶向远曲小管的自身抗体可导致获得性吉特曼综合征。最后,肾远端肾小管酸中毒或肾性尿崩症可由靶向集合管的自身抗体引起。在大多数情况下,自身抗体的特征仍不完整,疾病的发病机制也不清楚。我们认为,提高医生对自身抗体介导的肾小管疾病的认识,对于更好地估计患病率和改善患者护理非常重要。我们也希望能开展研究,以增进对自身抗体介导的肾小管疾病发病机制的了解。